BACKGROUND AND AIM: In the acute phase of acute myocardial infarction (AMI), reperfusion ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation (Reperfusion VT/VF) resulting from reperfusion injury are one of the causes of in-hospital death. Predicting Reperfusion VT/VF is clinically important. Previous studies have reported that oxidative stress is the cause of reperfusion injury and reperfusion arrhythmia. There are also reports that xanthine oxidase inhibitors have the effect of preventing reperfusion arrhythmia. We hypothesized that hyperuricemia is a risk factor for reperfusion arrhythmias in AMI. The aim of our study is to investigate whether serum uric acid is associated with Reperfusion VT/VF in acute myocardial infarction.
METHOD: This is a single-center, retrospective cohort study. We enrolled 612 ST elevation myocardial infarction patients who underwent successful primary percutaneous coronary intervention (PCI). We divided patients into a high serum uric acid group (HUA group) and a low serum uric acid group (LUA group) with a cutoff value of 7.0 mg/dl, which is the standard value of serum uric acid. We compared the frequency of Reperfusion VT/VF in both groups.
RESULT: There were 111 patients in the HUA group and 512 patients in the LUA group. Creatinine tended to be higher in the HUA group than in the LUA group. (1.12 ± 0.41 mg/dl VS 0.92 ± 1.10 mg/dl P = 0.06). The frequency of Reperfusion VT/VF was significantly higher in the HUA group than in the LUA group (17.1% VS 4.0% P < 0.001).
CONCLUSION: Elevated serum uric acid is associated with higher frequency of reperfusion ventricular arrhythmia.
